935 resultados para Whether costs may be awarded on indemnity basis
Resumo:
rnThis thesis is on the flavor problem of Randall Sundrum modelsrnand their strongly coupled dual theories. These models are particularly wellrnmotivated extensions of the Standard Model, because they simultaneously address rntherngauge hierarchy problem and the hierarchies in the quarkrnmasses and mixings. In order to put this into context, special attention is given to concepts underlying therntheories which can explain the hierarchy problem and the flavor structure of the Standard Model (SM). ThernAdS/CFTrnduality is introduced and its implications for the Randall Sundrum model withrnfermions in the bulk andrngeneral bulk gauge groups is investigated. It will be shown that the differentrnterms in the general 5D propagator of a bulk gauge field can be related tornthe corresponding diagrams of the strongly coupled dual, which allows for arndeeperrnunderstanding of the origin of flavor changing neutral currents generated by thernexchange of the Kaluza Klein excitations of these bulk fields.rnIn the numerical analysis, different observables which are sensitive torncorrections from therntree-levelrnexchange of these resonances will be presented on the basis of updatedrnexperimental data from the Tevatron and LHC experiments. This includesrnelectroweak precision observables, namely corrections to the S and Trnparameters followed by corrections to the Zbb vertex, flavor changingrnobservables with flavor changes at one vertex, viz. BR (Bd -> mu+mu-) and BR (Bs -> mu+mu-), and two vertices,rn viz. S_psiphi and |eps_K|, as well as bounds from direct detectionrnexperiments. rnThe analysis will show that all of these bounds can be brought in agreement withrna new physics scale Lambda_NP in the TeV range, except for the CPrnviolating quantity |eps_K|, which requires Lambda_NP= Ord(10) TeVrnin the absencernof fine-tuning. The numerous modifications of the Randall Sundrum modelrnin the literature, which try to attenuate this bound are reviewed andrncategorized.rnrnSubsequently, a novel solution to this flavor problem, based on an extendedrncolor gauge group in the bulk and its thorough implementation inrnthe RS model, will be presented, as well as an analysis of the observablesrnmentioned above in the extended model. This solution is especially motivatedrnfromrnthe point of view of the strongly coupled dual theory and the implications forrnstrongly coupled models of new physics, which do not possess a holographic dual,rnare examined.rnFinally, the top quark plays a special role in models with a geometric explanation ofrnflavor hierarchies and the predictions in the Randall-Sundrum model with andrnwithout the proposed extension for the forward-backward asymmetryrnA_FB^trnin top pair production are computed.
Resumo:
Der zunehmende Anteil von Strom aus erneuerbaren Energiequellen erfordert ein dynamisches Konzept, um Spitzenlastzeiten und Versorgungslücken aus der Wind- und Solarenergie ausgleichen zu können. Biogasanlagen können aufgrund ihrer hohen energetischen Verfügbarkeit und der Speicherbarkeit von Biogas eine flexible Energiebereitstellung ermöglichen und darüber hinaus über ein „Power-to-Gas“-Verfahren bei einem kurzzeitigen Überschuss von Strom eine Überlastung des Stromnetzes verhindern. Ein nachfrageorientierter Betrieb von Biogasanlagen stellt jedoch hohe Anforderungen an die Mikrobiologie im Reaktor, die sich an die häufig wechselnden Prozessbedingungen wie der Raumbelastung im Reaktor anpassen muss. Eine Überwachung des Fermentationsprozesses in Echtzeit ist daher unabdingbar, um Störungen in den mikrobiellen Gärungswegen frühzeitig erkennen und adäquat entgegenwirken zu können. rnBisherige mikrobielle Populationsanalysen beschränken sich auf aufwendige, molekularbiologische Untersuchungen des Gärsubstrates, deren Ergebnisse dem Betreiber daher nur zeitversetzt zur Verfügung stehen. Im Rahmen dieser Arbeit wurde erstmalig ein Laser-Absorptionsspektrometer zur kontinuierlichen Messung der Kohlenstoff-Isotopenverhältnisse des Methans an einer Forschungsbiogasanlage erprobt. Dabei konnten, in Abhängigkeit der Raumbelastung und Prozessbedingungen variierende Isotopenverhältnisse gemessen werden. Anhand von Isolaten aus dem untersuchten Reaktor konnte zunächst gezeigt werden, dass für jeden Methanogenesepfad (hydrogeno-troph, aceto¬klastisch sowie methylotroph) eine charakteristische, natürliche Isotopensignatur im Biogas nachgewiesen werden kann, sodass eine Identifizierung der aktuell dominierenden methanogenen Reaktionen anhand der Isotopen-verhältnisse im Biogas möglich ist. rnDurch den Einsatz von 13C- und 2H-isotopen¬markierten Substraten in Rein- und Mischkulturen und Batchreaktoren, sowie HPLC- und GC-Unter¬suchungen der Stoffwechselprodukte konnten einige bislang unbekannte C-Flüsse in Bioreaktoren festgestellt werden, die sich wiederum auf die gemessenen Isotopenverhältnisse im Biogas auswirken können. So konnte die Entstehung von Methanol sowie dessen mikrobieller Abbauprodukte bis zur finalen CH4-Bildung anhand von fünf Isolaten erstmalig in einer landwirtschaftlichen Biogasanlage rekonstruiert und das Vorkommen methylotropher Methanogenesewege nachgewiesen werden. Mithilfe molekularbiologischer Methoden wurden darüber hinaus methanoxidierende Bakterien zahlreicher, unbekannter Arten im Reaktor detektiert, deren Vorkommen aufgrund des geringen O2-Gehaltes in Biogasanlagen bislang nicht erwartet wurde. rnDurch die Konstruktion eines synthetischen DNA-Stranges mit den Bindesequenzen für elf spezifische Primerpaare konnte eine neue Methode etabliert werden, anhand derer eine Vielzahl mikrobieller Zielorganismen durch die Verwendung eines einheitlichen Kopienstandards in einer real-time PCR quantifiziert werden können. Eine über 70 Tage durchgeführte, wöchentliche qPCR-Analyse von Fermenterproben zeigte, dass die Isotopenverhältnisse im Biogas signifikant von der Zusammensetzung der Reaktormikrobiota beeinflusst sind. Neben den aktuell dominierenden Methanogenesewegen war es auch möglich, einige bakterielle Reaktionen wie eine syntrophe Acetatoxidation, Acetogenese oder Sulfatreduktion anhand der δ13C (CH4)-Werte zu identifizieren, sodass das hohe Potential einer kontinuierlichen Isotopenmessung zur Prozessanalytik in Biogasanlagen aufgezeigt werden konnte.rn
Resumo:
Studies with very long follow-up are scarce in patients with cryptogenic stroke and patent foramen ovale (PFO). Little is known about the etiology of recurrent cerebrovascular events (CVE) in PFO patients.
Resumo:
Ligands of the benzodiazepine binding site of the GABA(A) receptor come in three flavors: positive allosteric modulators, negative allosteric modulators and antagonists all of which can bind with high affinity. The GABA(A) receptor is a pentameric protein which forms a chloride selective ion channel and ligands of the benzodiazepine binding site stabilize three different conformations of this protein. Classical benzodiazepines exert a positive allosteric effect by increasing the apparent affinity of channel opening by the agonist γ-aminobutyric acid (GABA). We concentrate here on the major adult isoform, the α(1)β(2)γ(2) GABA(A) receptor. The classical binding pocket for benzodiazepines is located in a subunit cleft between α(1) and γ(2) subunits in a position homologous to the agonist binding site for GABA that is located between β(2) and α(1) subunits. We review here approaches to this picture. In particular, point mutations were performed in combination with subsequent analysis of the expressed mutant proteins using either electrophysiological techniques or radioactive ligand binding assays. The predictive power of these methods is assessed by comparing the results with the predictions that can be made on the basis of the recently published crystal structure of the acetylcholine binding protein that shows homology to the N-terminal, extracellular domain of the GABA(A) receptor. In addition, we review an approach to the question of how the benzodiazepine ligands are positioned in their binding pocket. We also discuss a newly postulated modulatory site for benzodiazepines at the α(1)/β(2) subunit interface, homologous to the classical benzodiazepine binding pocket.
Resumo:
Vinblastine sulphate (VBS) is an anticancer drug that acts by disrupting microtubule dynamics of highly mitotic tissue cells. The consequences of VBS on the olfactory mucosa (OM), a tissue with high mitotic numbers, are not clearly understood. We used qualitative and quantitative methods to determine the structural changes that may be produced on the rabbit OM by VBS. Following a single dose (0.31 mg/kg) of this drug, the structure of the mucosa was greatly altered on the first 3-5 days. The alteration was characterized by disarrangement of the normal layering of nuclei of the epithelia, degeneration of axonal bundles, occurrence of blood vessels within the bundles, localized death of cells of Bowman's glands and glandular degeneration. Surprisingly on or after day 7 and progressively to day 15 post-exposure, the OM was observed to regenerate and acquire normal morphology, and the vessels disappeared from the bundles. Relative to control values, bundle diameters, olfactory cell densities and cilia numbers decreased to as low as 53.1, 75.2 and 71.4%, respectively, on day 5. Volume density for the bundles, which was 28.6% in controls, decreased to a lowest value of 16.8% on day 5. In contrast, the volume density for the blood vessels was significantly lower in controls (19.9%) than in treated animals at day 2 (25.8%), day 3 (34.3%) and day 5 (31.5%). These findings suggest that the changes induced on the rabbit OM by VBS are transient and that regenerative recovery leads to the restoration of the normal structure of the mucosa.
Resumo:
This study sought to compare all-cause mortality in patients at intermediate surgical risk undergoing transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR).
Resumo:
BACKGROUND: Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur. The aim of this study was to determine the nature of the latter in treated cases of the disease and to assess their impact on visual function. METHODS: Four hundred and thirty consecutive children with serologically confirmed congenital toxoplasmosis were included in this study. Data were prospectively collected using standardized ophthalmological assessment forms. The presence of retinochoroiditis and of associated pathologies was ascertained, and their impact on visual function was assessed. RESULTS: After a median follow-up of 12 years [range 0.6-26 years], 130 children manifested retinochoroiditis. We detected 22 foci of retinochoroiditis at birth and 264 additional ones during the follow-up period. Of these, 48 (17%) were active when first diagnosed. Twenty-five of the 130 children (19%) had other associated ocular pathologies. Of these, 21 (16%) had a strabismus, which was due to macular lesions in 86% of the cases; 7 (5.4%) presented with unilateral microphthalmia, and 4 (3%) with cataracts. Most of these events were detected after the onset of retinochoroiditis. None of the children presented with ocular involvement in the absence of chorioretinal lesions. Macular lesions occurred more frequently in children with associated pathologies (p<0.0001), and associated pathologies were likewise more common in individuals with macular lesions (p=0.0003). Visual impairment occurred in 31/130 cases, and in all but 3 of these eyes it was due not to an associated pathology but to macular retinochoroiditis. CONCLUSIONS: At the end of the follow-up period, ocular involvement existed in 30% of the treated children with congenital toxoplasmosis. Associated eye pathologies were manifested less frequently than anticipated. They may occur later in life and are an indirect marker of the severity of congenital toxoplasmosis, but they do not have a direct impact on visual acuity. The overall functional prognosis of congenital toxoplasmosis is better than would be expected on the basis of literature findings, with only 2 of the 130 children suffering bilateral visual impairment.
Resumo:
Peptide hormone receptors overexpressed in human tumors, such as somatostatin receptors, can be used for in vivo targeting for diagnostic and therapeutic purposes. A novel promising candidate in this field is the GLP-1 receptor, which was recently shown to be massively overexpressed in gut and lung neuroendocrine tumors--in particular, in insulinomas. Anticipating a major development of GLP-1 receptor targeting in nuclear medicine, our aim was to evaluate in vitro the GLP-1 receptor expression in a large variety of other tumors and to compare it with that in nonneoplastic tissues. METHODS: The GLP-1 receptor protein expression was qualitatively and quantitatively investigated in a broad spectrum of human tumors (n=419) and nonneoplastic human tissues (n=209) with receptor autoradiography using (125)I-GLP-1(7-36)amide. Pharmacologic competition experiments were performed to provide proof of specificity of the procedure. RESULTS: GLP-1 receptors were expressed in various endocrine tumors, with particularly high amounts in pheochromocytomas, as well as in brain tumors and embryonic tumors but not in carcinomas or lymphomas. In nonneoplastic tissues, GLP-1 receptors were present in generally low amounts in specific tissue compartments of several organs--namely, pancreas, intestine, lung, kidney, breast, and brain; no receptors were identified in lymph nodes, spleen, liver, or the adrenal gland. The rank order of potencies for receptor binding--namely, GLP-1(7-36)amide = exendin-4 >> GLP-2 = glucagon(1-29)--provided proof of specific GLP-1 receptor identification. CONCLUSION: The GLP-1 receptors may represent a novel molecular target for in vivo scintigraphy and targeted radiotherapy for a variety of GLP-1 receptor-expressing tumors. For GLP-1 receptor scintigraphy, a low-background signal can be expected, on the basis of the low receptor expression in the normal tissues surrounding tumors.
Resumo:
BACKGROUND AND OBJECTIVES: The thrombotic thrombocytopenic purpura-hemolytic uremic syndromes (TTP-HUS) have diverse etiologies, clinical manifestations, and risk factors, but the events that may trigger acute episodes are often unclear. We describe the occurrence of TTP-HUS following pancreatitis and consider whether pancreatitis may be a triggering event for acute episodes of TTP-HUS. DESIGN AND METHODS: We report on three patients from the Oklahoma Registry and two patients from Northwestern University who had an acute episode of TTP-HUS following pancreatitis. A systematic review of published case reports was performed to identify additional patients who had TTP-HUS following pancreatitis. RESULTS. In each of our five patients there was an apparent etiology of alcoholism or common bile duct obstruction for the pancreatitis and no evidence of TTP-HUS when the pancreatitis was diagnosed. Two patients had severe ADAMTS13 deficiency with an inhibitor; in one of these patients TTP-HUS recurred following a subsequent recurrent episode of pancreatitis. The systematic review identified 16 additional patients who had TTP-HUS following pancreatitis; recurrent TTP-HUS occurred in three of these patients following a subsequent episode of recurrent pancreatitis. In all 21 patients, the interval between the diagnosis of pancreatitis and TTP-HUS was short (1-13 days; median, 3 days). The three Oklahoma patients represent approximately 1% of the 356 patients in the Registry. INTERPRETATION AND CONCLUSIONS: These observations suggest that in some patients pancreatitis, a disorder that results in an intense systemic inflammatory response, may be a triggering event for acute episodes of TTP-HUS.
Resumo:
Two bombesin analogs, Demobesin 4 and Demobesin 1, were characterized in vitro as gastrin-releasing peptide (GRP) receptor agonist and antagonist, respectively, and were compared as (99m)Tc-labeled ligands for their in vitro and in vivo tumor-targeting properties. METHODS: N(4)-[Pro(1),Tyr(4),Nle(14)]Bombesin (Demobesin 4) and N(4)-[d-Phe(6),Leu-NHEt(13),des-Met(14)]bombesin(6-14) (Demobesin 1) were characterized in vitro for their binding properties with GRP receptor autoradiography using GRP receptor-transfected HEK293 cells, PC3 cells, and human prostate cancer specimens. Their ability to modulate calcium mobilization in PC3 and transfected HEK293 cells was analyzed as well as their ability to trigger internalization of the GRP receptor in transfected HEK293 cells, as determined qualitatively by immunofluorescence microscopy and quantitatively by enzyme-linked immunosorbent assay (ELISA). Further, their internalization properties as (99m)Tc-labeled radioligands were tested in vitro in both cell lines. Finally, their biodistribution was analyzed in PC3 tumor-bearing mice. RESULTS: A comparable binding affinity with the 50% inhibitory concentration (IC(50)) in the nanomolar range was measured for Demobesin 4 and Demobesin 1 in all tested tissues. Demobesin 4 behaved as an agonist by strongly stimulating calcium mobilization and by triggering GRP receptor internalization. Demobesin 1 was ineffective in stimulating calcium mobilization and in triggering GRP receptor internalization. However, in these assays, it behaved as a competitive antagonist as it reversed completely the agonist-induced effects in both systems. (99m)Tc-Labeled Demobesin 1 was only weakly taken up by PC3 cells or GRP receptor-transfected HEK293 cells (10% and 5%, respectively, of total added radioactivity) compared with (99m)Tc-labeled Demobesin 4 (45% of total added radioactivity in both cell lines). Remarkably, the biodistribution study revealed a much more pronounced uptake at 1, 4, and 24 h after injection of (99m)Tc-labeled Demobesin 1 in vivo into PC3 tumors than (99m)Tc-labeled Demobesin 4. In vivo competition experiments demonstrated a specific uptake in PC3 tumors and in physiologic GRP receptor-expressing tissues. The tumor-to-kidney ratios were 0.7 for Demobesin 4 and 5.2 for Demobesin 1 at 4 h. CONCLUSION: This comparative in vitro/in vivo study with Demobesin 1 and Demobesin 4 indicates that GRP receptor antagonists may be superior targeting agents to GRP receptor agonists, suggesting a change of paradigm in the field of bombesin radiopharmaceuticals.
Resumo:
There is poor agreement on definitions of different phenotypes of preschool wheezing disorders. The present Task Force proposes to use the terms episodic (viral) wheeze to describe children who wheeze intermittently and are well between episodes, and multiple-trigger wheeze for children who wheeze both during and outside discrete episodes. Investigations are only needed when in doubt about the diagnosis. Based on the limited evidence available, inhaled short-acting beta(2)-agonists by metered-dose inhaler/spacer combination are recommended for symptomatic relief. Educating parents regarding causative factors and treatment is useful. Exposure to tobacco smoke should be avoided; allergen avoidance may be considered when sensitisation has been established. Maintenance treatment with inhaled corticosteroids is recommended for multiple-trigger wheeze; benefits are often small. Montelukast is recommended for the treatment of episodic (viral) wheeze and can be started when symptoms of a viral cold develop. Given the large overlap in phenotypes, and the fact that patients can move from one phenotype to another, inhaled corticosteroids and montelukast may be considered on a trial basis in almost any preschool child with recurrent wheeze, but should be discontinued if there is no clear clinical benefit. Large well-designed randomised controlled trials with clear descriptions of patients are needed to improve the present recommendations on the treatment of these common syndromes.
Resumo:
The problem of re-sampling spatially distributed data organized into regular or irregular grids to finer or coarser resolution is a common task in data processing. This procedure is known as 'gridding' or 're-binning'. Depending on the quantity the data represents, the gridding-algorithm has to meet different requirements. For example, histogrammed physical quantities such as mass or energy have to be re-binned in order to conserve the overall integral. Moreover, if the quantity is positive definite, negative sampling values should be avoided. The gridding process requires a re-distribution of the original data set to a user-requested grid according to a distribution function. The distribution function can be determined on the basis of the given data by interpolation methods. In general, accurate interpolation with respect to multiple boundary conditions of heavily fluctuating data requires polynomial interpolation functions of second or even higher order. However, this may result in unrealistic deviations (overshoots or undershoots) of the interpolation function from the data. Accordingly, the re-sampled data may overestimate or underestimate the given data by a significant amount. The gridding-algorithm presented in this work was developed in order to overcome these problems. Instead of a straightforward interpolation of the given data using high-order polynomials, a parametrized Hermitian interpolation curve was used to approximate the integrated data set. A single parameter is determined by which the user can control the behavior of the interpolation function, i.e. the amount of overshoot and undershoot. Furthermore, it is shown how the algorithm can be extended to multidimensional grids. The algorithm was compared to commonly used gridding-algorithms using linear and cubic interpolation functions. It is shown that such interpolation functions may overestimate or underestimate the source data by about 10-20%, while the new algorithm can be tuned to significantly reduce these interpolation errors. The accuracy of the new algorithm was tested on a series of x-ray CT-images (head and neck, lung, pelvis). The new algorithm significantly improves the accuracy of the sampled images in terms of the mean square error and a quality index introduced by Wang and Bovik (2002 IEEE Signal Process. Lett. 9 81-4).